Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +47.56%
#3 Cysic Cysic +41.67%
#4 Glidr Glidr +36.41%
#5 Walrus Walrus +29.37%
#6 Humanity Humanity +23.38%
#7 Codatta Codatta +16.38%
#8 Enso Enso +16.32%
#9 Tutorial Tutorial +15.81%
#10 Ribbita by Virtuals Ribbita by Virtuals +14.43%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rangering i aksjer #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Aksjekurs
$0.6
Sist synkronisert: 2024-08-14
Markedsverdi
$2.09M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
SG
Handel ASLAN Pharmaceuticals Limited (ASLN)

Kategori

Healthcare
Antall utestående aksjer for ASLAN Pharmaceuticals Limited (ASLN)
Antall utestående aksjer per March 2024: 4.67M
Ifølge ASLAN Pharmaceuticals Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 4.67M. Ved slutten av December 2022 hadde selskapet 3.49M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for ASLAN Pharmaceuticals Limited (ASLN) fra 2014 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 4.67M 13.50%
2023 4.11M 17.93%
2022 3.49M 7.07%
2021 3.26M 69.43%
2020 1.92M 18.37%
2019 1.62M 8.45%
2018 1.50M 20.35%
2017 1.24M -4.34%
2016 1.30M 136.41%
2015 550.22K 761.10%
2014 63.90K 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,339.61%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,232.28%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE